Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug, Other
  • Participants: 74
  • Start Date: October 1, 2021
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: September 1, 2021
A Study to Evaluate the Safety and Efficacy of PV-001-DV in Combination With Infusion of PV-001-DC in Patients With Advanced Melanoma
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: September 1, 2021
A Study to Evaluate the Safety and Efficacy of PV-001-DV in Combination With Infusion of PV-001-DC in Patients With Advanced Melanoma
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Biological
  • Participants: 500
  • Start Date: July 2021
Dengvaxia US Pregnancy Registry: A Surveillance Study to Assess the Safety of Dengvaxia Among Exposed Pregnant Women and Their Offsprings (DNG00044)
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 214
  • Start Date: June 2021
A Pregnancy Registry to Evaluate the Safety of Dengue Vaccine Among Inadvertently Exposed Pregnant Women and Their Offsprings (DNG16)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 60
  • Start Date: April 1, 2021
Efficacy of Cannabidiol in Combination With Red Algae (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection PASC
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Other
  • Participants: 80
  • Start Date: March 23, 2021
Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-Endemic Participants in Cambodia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Combination Product, Biological, Drug
  • Participants: 360
  • Start Date: February 2021
(Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 294
  • Start Date: January 25, 2021
High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial
Showing 1-12 of 49